Finance

Beta
Lists
ECOR:NASDAQ
electroCore, Inc.
$10.25
+0.69%
(+0.070) 1D
Jun 12, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECOR...
Open
$10.17
High
$10.45
Low
$9.80
Mkt. cap
85.03M
Avg. vol.
139.26K
Volume
153.53K
52-wk high
$10.45
52-wk low
$4.16
EPS
-$1.78
Beta
0.83
Shares outstanding
8.30M
No. of employees
83
Open
$10.17
High
$10.45
Low
$9.80
Mkt. cap
85.03M
Avg. vol.
139.26K
Volume
153.53K
52-wk high
$10.45
52-wk low
$4.16
EPS
-$1.78
Beta
0.83
Shares outstanding
8.30M
No. of employees
83
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ECOR in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ECOR in the last 3 months.
Highest
Current $10.25
$19.85 (+93.66%)
Average
$16.62 (+62.15%)
Lowest
$12.00 (+17.07%)
News stories
From sources across the web
Profile
electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation. Wikipedia
About electroCore, Inc.
CEO-
Employees83
Founded2005
HeadquartersRockaway, New Jersey, United States
SectorMedical device
Websiteelectrocore.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.38M
8.69M
9.24M
9.58M
Cost of goods sold
939.00K
1.22M
1.07M
1.22M
Cost of revenue
939.00K
1.22M
1.07M
1.22M
Research and development expenses
511.00K
662.00K
920.00K
740.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.44M
9.69M
10.19M
12.94M
Operating expense
9.95M
10.35M
11.11M
13.68M
Total operating expenses
10.89M
11.57M
12.18M
14.90M
Operating income
-3.51M
-2.88M
-2.94M
-5.32M
Other non operating income
-233.00K
-375.00K
714.00K
-10.00K
EBT including unusual items
-3.67M
-3.40M
-2.98M
-5.59M
EBT excluding unusual items
-3.67M
-3.40M
-2.47M
-5.59M
Income tax expense
-
-
51.00K
-321.00K
Effective tax rate
-
-
-1.71%
5.74%
Other operating expenses
-
-
-
-
Net income
-3.67M
-3.40M
-3.04M
-5.27M
Net profit margin
-49.74%
-39.19%
-32.84%
-55.00%
Earnings per share
-
-
-
-
Interest and investment income
68.00K
62.00K
85.00K
52.00K
Interest expense
-
-208.00K
-324.00K
-318.00K
Net interest expenses
68.00K
-146.00K
-239.00K
-266.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.38M
-2.77M
-2.83M
-5.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer